The confirmatory IGNYTE-3 trial is assessing RP1 in combination with nivolumab in patients with advanced melanoma who have progressed on anti-PD-1 and anti-CTLA-4 therapies or are ineligible for ...
The runway shows by Prada, Giorgio Armani and Emporio Armani and Zegna, which anchored the four-day calendar, were widely praised, as were the presentations from tailoring brands ranging from Brunello ...